Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Cardiology

Cardiac Monitoring and Individualized Care

At a Glance

In Slovenian-type heart-hand syndrome, heart rhythm problems can develop or change with age even when heart structure and pumping look normal. Personalized ECGs, rhythm monitoring, imaging, and specialist follow-up help guide treatment and emergency planning.

In Heart-Hand Syndrome, Slovenian type, the hand features (brachydactyly) are present from birth and do not change. However, the heart features can be age-dependent, meaning they can develop or change over many years [1][2]. Because rhythm issues can occur even when the heart muscle still appears structurally strong, proactive monitoring is a critical part of care [3].

Your Cardiac Care Team

Because this condition is so rare and involves complex electrical issues, your care should ideally be managed by a cardiologist with expertise in inherited cardiac diseases or electrophysiology (heart rhythm) [4]. They will create a personalized surveillance schedule for you, as there is no single, mandatory schedule that applies to everyone with this specific variant.

Routine Monitoring Tools

Monitoring is designed to catch changes before they cause major symptoms. Depending on your age, symptoms, genotype, and prior findings, your doctor may utilize:

  • 12-Lead ECG: Often performed at check-ups to look for changes in the P-wave or signs that electrical signals are slowing down (conduction disease) [5][6].
  • Ambulatory Rhythm Monitoring: You may wear a Holter monitor or a “patch” for 24 hours to several days. This is used to detect “silent” arrhythmias that an office ECG might miss [5][7].
  • Echocardiogram: An ultrasound used to check the size and “squeeze” (ejection fraction) of your heart chambers [5].
  • Cardiac MRI (CMR): This may be done at baseline and then periodically when clinically indicated. It can look for fibrosis (scarring) in the heart muscle (often called late gadolinium enhancement), which is a risk marker for future complications [8][9].

Managing Heart Rhythm Issues

If monitoring shows that the heart’s electrical system is struggling, your doctor will discuss individualized treatments. Never start, stop, or change medications without consulting your treating clinician.

Pacemakers and Defibrillators (ICDs)

Depending on what specific issues arise, doctors might consider an implanted device:

  • Pacemaker: This may be recommended if the heart’s electrical signals are too slow or blocked (bradycardia or heart block) [1].
  • ICD (Implanted Cardioverter Defibrillator): Some LMNA variants carry a risk for dangerous, rapid rhythms in the lower chambers (ventricular arrhythmias). An ICD can “shock” the heart back into a normal rhythm. Doctors use specific risk tools that look at defined clinical variables (like sex, ejection fraction, and documented nonsustained ventricular tachycardia—not just subjective feelings of “skipped beats”) to estimate this risk. These tools are often generalized for LMNA cardiomyopathy and must be carefully weighed for this rare variant [10][11].

Medications and Procedures

  • Anticoagulation (Blood Thinners): If you develop atrial fibrillation or flutter, you may be at higher risk for stroke. However, anticoagulation is not automatic just because you have an LMNA variant. The decision to use blood thinners is based on an individualized assessment of your stroke risk factors, bleeding risk, and the type of arrhythmia you have [12].
  • Ablation/Rhythm Control: For some arrhythmias, doctors may use medications or an ablation procedure (using heat or cold to neutralize the tiny area of tissue causing the irregular rhythm) [13][14].

Cardiac Red Flags: When to Seek Help

While the hand features of this syndrome are never an emergency, certain heart symptoms require swift evaluation.

Call 911 or go to the nearest emergency room immediately (do NOT drive yourself) if you experience:

  • Syncope (Fainting): Any sudden loss of consciousness is a major red flag [11].
  • Severe Chest Pain or Pressure: Any new or worsening severe chest discomfort.
  • Severe Breathlessness: Sudden difficulty breathing, gasping for air, or inability to breathe while lying flat.
  • Sustained, Violent Palpitations: A racing, chaotic heartbeat accompanied by dizziness or feeling like you might pass out.

Contact your cardiology team promptly (for a same-day or urgent assessment) if you experience:

  • New or Worsening Fatigue: A dramatic drop in your ability to walk or exercise that doesn’t improve.
  • Persistent Palpitations: “Skipped beats” or fluttering that continues longer than usual but without fainting or severe dizziness.
  • Leg Swelling or Rapid Weight Gain: Signs that your heart may not be pumping fluid efficiently.

Common questions in this guide

How often should I have heart checks for Slovenian-type heart-hand syndrome?
There is no single schedule for everyone with Slovenian-type heart-hand syndrome. A cardiologist familiar with inherited heart conditions sets the timing based on your age, symptoms, gene variant, and previous results. Checks may include an office ECG, a wearable rhythm monitor, an echocardiogram, and a cardiac MRI when appropriate.
What tests monitor the heart in Slovenian-type heart-hand syndrome?
A 12-lead ECG checks the heart’s electrical signals and whether they are moving normally. A Holter or patch monitor records the rhythm for a day or longer and can find episodes missed during a clinic visit. An echocardiogram assesses heart size and pumping, while an MRI may look for scar tissue.
When might a pacemaker or ICD be needed?
A pacemaker may be considered when the heart’s electrical signals are too slow or blocked. An ICD may be considered when a person has a meaningful risk of life-threatening fast rhythms from the lower heart chambers, based on factors such as pumping function and a documented brief fast rhythm. The decision is individualized and does not follow from an LMNA gene variant alone.
Do I automatically need blood thinners if I have an LMNA variant or heart-hand syndrome?
No. Blood thinners may be considered if atrial fibrillation or flutter develops, after the clinician weighs stroke risk, bleeding risk, and the type of rhythm problem. Do not start, stop, or change medication without discussing it with your treating clinician.
Which symptoms mean I should go to the emergency room?
Call 911 and do not drive yourself for fainting, severe or new chest pressure, sudden severe trouble breathing, or a sustained chaotic racing heartbeat with dizziness or near-fainting. Contact your cardiology team urgently for new major fatigue, persistent palpitations without severe symptoms, leg swelling, or rapid weight gain.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my specific gene variant and health history, what should my personalized surveillance schedule look like?
  2. 2.If I am experiencing palpitations or skipped beats, how will we determine if they are related to atrial issues or ventricular issues?
  3. 3.Does my most recent cardiac MRI show any 'late gadolinium enhancement' (fibrosis), and how does that factor into my risk assessment?
  4. 4.If I develop an atrial arrhythmia, how will we assess my stroke risk and decide if a blood thinner is right for me?
  5. 5.Since this condition can progress even if my heart 'squeeze' (ejection fraction) is normal, what specific markers are you looking for to decide if my treatment needs to change?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.

    Kumar S, Baldinger SH, Gandjbakhch E, et al.

    Journal of the American College of Cardiology 2016; (68(21)):2299-2307 doi:10.1016/j.jacc.2016.08.058.

    PMID: 27884249
  2. 2

    Contemporary Insights into LMNA Cardiomyopathy.

    Balakrishnan ID, Lakdawala NK

    Current cardiology reports 2025; (27(1)):40.

    PMID: 39869235
  3. 3

    Cardiac and Neuromuscular Features of Patients With LMNA-Related Cardiomyopathy.

    Peretto G, Di Resta C, Perversi J, et al.

    Annals of internal medicine 2019; (171(7)):458-463 doi:10.7326/M18-2768.

    PMID: 31476771
  4. 4

    Lamin A/C Cardiomyopathy: Implications for Treatment.

    Chen SN, Sbaizero O, Taylor MRG, Mestroni L

    Current cardiology reports 2019; (21(12)):160 doi:10.1007/s11886-019-1224-7.

    PMID: 31773301
  5. 5

    Characterization of cardiac involvement in children with LMNA-related muscular dystrophy.

    Cesar S, Campuzano O, Cruzalegui J, et al.

    Frontiers in cell and developmental biology 2023; (11()):1142937 doi:10.3389/fcell.2023.1142937.

    PMID: 36968203
  6. 6

    Familial atrial myopathy in a large multigenerational heart-hand syndrome pedigree carrying an LMNA missense variant in rod 2B domain (p.R335W).

    Zhang Y, Lin Y, Zhang Y, et al.

    Heart rhythm 2022; (19(3)):466-475 doi:10.1016/j.hrthm.2021.11.022.

    PMID: 34808346
  7. 7

    The role of detailed medical history for the early diagnosis of familial bradycardia in a patient with associated atrial fibrillation: case report.

    Ciacaru A, Tusa A, Magdas A, Podoleanu C

    European heart journal. Case reports 2024; (8(3)):ytae116 doi:10.1093/ehjcr/ytae116.

    PMID: 38476290
  8. 8

    Late gadolinium enhancement role in arrhythmic risk stratification of patients with LMNA cardiomyopathy: results from a long-term follow-up multicentre study.

    Peretto G, Barison A, Forleo C, et al.

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2020; (22(12)):1864-1872 doi:10.1093/europace/euaa171.

    PMID: 32995851
  9. 9

    Variant-Specific Late Gadolinium Enhancement Patterns Influence Clinical Outcomes in LMNA-Related Cardiomyopathy.

    Castrichini M, Garmany R, Siontis KC, et al.

    Journal of the American Heart Association 2025; (14(15)):e041230 doi:10.1161/JAHA.124.041230.

    PMID: 40689545
  10. 10

    Risk predictors in a Spanish cohort with cardiac laminopathies. The REDLAMINA registry.

    Barriales-Villa R, Ochoa JP, Larrañaga-Moreira JM, et al.

    Revista espanola de cardiologia (English ed.) 2021; (74(3)):216-224 doi:10.1016/j.rec.2020.03.026.

    PMID: 32616434
  11. 11

    Missense and Non-Missense Lamin A/C Gene Mutations Are Similarly Associated with Major Arrhythmic Cardiac Events: A 20-Year Single-Centre Experience.

    Forleo C, Carella MC, Basile P, et al.

    Biomedicines 2024; (12(6)) doi:10.3390/biomedicines12061293.

    PMID: 38927500
  12. 12

    Intrinsic Atrial Myopathy Precedes Left Ventricular Dysfunction and Predicts Atrial Fibrillation in Lamin A/C Cardiomyopathy.

    Tremblay-Gravel M, Ichimura K, Picard K, et al.

    Circulation. Genomic and precision medicine 2023; (16(1)):e003480 doi:10.1161/CIRCGEN.121.003480.

    PMID: 36548481
  13. 13

    Outcomes of Ventricular Tachycardia Ablation in Cardiac Laminopathy: An Updated Systematic Review and Single-Arm Meta-Analysis.

    Castrichini M, Ferreira Felix I, Karlinski Vizentin V, et al.

    Journal of cardiovascular electrophysiology 2026; (37(2)):268-274 doi:10.1111/jce.70193.

    PMID: 41331778
  14. 14

    Multicenter Experience With Catheter Ablation for Ventricular Tachycardia in Lamin A/C Cardiomyopathy.

    Kumar S, Androulakis AF, Sellal JM, et al.

    Circulation. Arrhythmia and electrophysiology 2016; (9(8)).

    PMID: 27506821

This page is for informational purposes only and does not constitute medical advice. A cardiologist or electrophysiologist should tailor your monitoring, treatment, and emergency plan to your specific gene variant and health history.

Get notified when new evidence is published on Heart-hand syndrome, Slovenian type.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.